4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-382456
President, Oncology sold 58,333 shares at an average $110.76 ($6,460,766)
- President, Oncology acquired 58,333 shares (option exercise)
- President, Oncology acquired 276 shares (grant or award)
- President, Oncology gave up 102 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Vieira Roberto Wandenkolk · President, Oncology
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant or award : show line 1 in the form 10b5-1 | +138 | $113.38 | $15,646 | 4,206 | D |
| 2026-09-01 | Grant or award : show line 2 in the form 10b5-1 | +138 | 4,344 | D | ||
| 2026-09-02 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −102 | $113.38 | $11,565 | 4,242 | D |
| 2026-09-02 | Exercise or conversion : show line 4 in the form 10b5-1 | +58,333 | $21.63 | $1,261,743 | 62,575 | D |
| 2026-09-02 | Sale : show line 5 in the form 10b5-1 | −23,600 | $109.35 | $2,580,674 | 38,975 | D |
| 2026-09-02 | Sale : show line 6 in the form 10b5-1 | −23,770 | $110.70 | $2,631,349 | 15,205 | D |
| 2026-09-02 | Sale : show line 7 in the form 10b5-1 | −1,537 | $111.37 | $171,181 | 13,668 | D |
| 2026-09-02 | Sale : show line 8 in the form 10b5-1 | −974 | $112.40 | $109,474 | 12,694 | D |
| Open-market sales · 58,333 sh · avg $110.76 · $6,460,766 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-02 | Exercise or conversion : show line 12 in the form 10b5-1 Stock option (right to buy) | −58,333 | 141,667 | D |
Loading xslF345X06/ownership.xml…